Informação da revista
Vol. 31. Núm. 3.
Páginas 193-201 (março 2012)
Partilhar
Partilhar
Baixar PDF
Mais opções do artigo
Vol. 31. Núm. 3.
Páginas 193-201 (março 2012)
Original article
Open Access
Implementation of a pre-hospital network favoring primary angioplasty in STEMI to reduce mortality: The Algarve Project
Visitas
5067
Veloso Gomes
Autor para correspondência
mvelosogomes@sapo.pt

Corresponding author.
, Victor Brandão, Jorge Mimoso, Paula Gago, Joana Trigo, Walter Santos, Nuno Marques, Rui Candeias, Salomé Pereira, Vasco Marques, Ana Camacho, Ilídio de Jesus
Department of Cardiology, Faro Hospital, Faro, Portugal
Este item recebeu

Under a Creative Commons license
Informação do artigo
Abstract
Objective

To analyze the impact of reperfusion by either primary percutaneous coronary inter-vention (PPCI) or fibrinolysis, and mortality rates of a pre-hospital fast-track network for treating patients with ST-elevation myocardial infarction (STEMI).

Methods and Results

A pre-hospital network for STEMI patients, designated the Green Lane for Acute Myocardial Infarction (GL-AMI), has been implemented in the southern region of Portugal - the Algarve Project. We performed an observational study based on a prospective registry of 1338 patients admitted to Faro Hospital between 2004 and 2009, classified in two groups according to the method of admission: emergency department group (EDG) and GL-AMI group (GLG). More patients from GLG were reperfused (p<0.0001). PPCI was the preferred method of reperfusion, 73.1% in GLG and 45.3% in EDG. Time delays were significantly shorter in GLG, except for pre-hospital delay: pre-hospital delay (p=0.11); door-to-needle (p<0.0001); door-to-balloon (p<0.0001); and delay between symptoms and reperfusion (p<0.0001). In-hospital mortality (4.3% vs 9.2%, p=0.0007) and 6-month mortality (6.3% vs 13.8%, p<0.0001) were significantly lower in GLG.

Conclusions

The Algarve Project significantly reduced the time delay between onset of symp-toms and reperfusion, significantly increased the rate of reperfusion, and significantly reduced in-hospital and six-month mortality.

Keywords:
ST-elevation myocardial infarction
Treatment delays
Reperfusion therapy
Pre-hospital clinical network
Mortality
Resumo
Objetivo

Analisar o impacto nas taxas de reperfusão por intervenc¸ão coronária percutânea primária (PPCI) ou fibrinólise, e na mortalidade de uma rede pré-hospitalar para o tratamento de doentes com enfarte agudo do miocárdio com elevac¸ão do segmento ST.

Métodos e Resultados

A rede pré-hospitalar para doentes com enfarte agudo do miocárdio, designada Via Verde para o Enfarte Agudo do Miocárdio (GW-AMI), tem sido implementada na região sul de Portugal - O Projeto Algarve. Realizamos um estudo observacional, baseado num registo prospetivo de 1338 doentes internados no Hospital de Faro entre 2004 e 2009, classifica-dos em dois grupos de acordo com a forma de admissão: grupo do Servic¸o de Urgência (EDG) e grupo GW-AMI (GTG). Mais doentes do GTG foram reperfundidos (p<0,0001). PPCI foi o método preferencial de reperfusão, 73,1% no GTG e 45,3% no EDG. Os tempos de demora foram significa-tivamente inferiores no GTG, exceto o atraso pré-hospitalar: Tempo pré-hospitalar (p=0,11); Porta-agulha (p<0,0001); Porta-balão (p<0,0001); Tempo sintomas-reperfusão (p<0,0001). As taxas de mortalidade hospitalar (4,3% versus 9,2%, p=0,0007) e mortalidade aos 6 meses (6,3% versus 13,8%, p<0,0001) foram significativamente inferiores no GTG.

Conclusões

O Projeto Algarve reduziu significativamente os tempos de demora entre o iní-cio dos sintomas e reperfusão, aumentou significativamente a taxa de reperfusão e diminuiu significativamente as taxas de mortalidade hospitalar e aos seis meses.

Palavras-chave:
Enfarte agudo do miocárdio com elevação do segmento ST
Tempos de demora
Terapia de reperfusão
Rede pré-hospital
Mortalidade
O texto completo está disponível em PDF
References
[1]
F. Van de Werf, J. Bax, A. Betriu, et al.
Management of acute myocardial infarction in patients presenting with persistent ST- segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the Euro-pean Society of Cardiology.
Eur Heart J., 29 (2008), pp. 2909-2945
[2]
G. De Luca, H. Suryapranata, J.P. Ottervanger, et al.
Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.
Circula-tion., 109 (2004), pp. 1223-1225
[3]
B.K. Nallamothu, E.R. Bates, J. Herrin, et al.
NRMI Investigators. Times to treatment in transfer patients undergoing primary per-cutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis.
Circulation, 111 (2005), pp. 761-767
[4]
M. Flesh, J. Hagemeister, H.J. Berger, et al.
Implementation of guidelines for the treatment of acute ST-elevation myocardial infarction: The Cologne Infarction Model Registry.
[5]
J. Trigo, P. Gago, J. Mimoso, et al.
Tempo de demora intra-hospitalar após triagem de Manchester nos Enfartes Agu-dos do Miocárdio com elevac¸ão de ST.
Rev Port Cardiol., 27 (2008), pp. 1251-1259
[6]
J.H. Chesebro, G. Knatterud, R. Roberts, et al.
Thrombolysis In Myocardial Infarction (TIMI) Trial, phase I: a compari-son between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital dis-charge.
Circulation., 76 (1987), pp. 142-154
[7]
F.A. Masoudi, R.O. Bonow, R.G. Brindis, et al.
ACC/AHA Task Force on Performance Measures. ACC/AHA 2008 statement on performance measurement and reperfusion therapy: a report of the ACC/AHA task force on performance measures (Work group to address the challenges of performance measure-ment and reperfusion therapy).
J Am Coll Cardiol., 52 (2008), pp. 2101-2112
[8]
P. Widimsky, J. Fajadet, N. Danchin, et al.
“Stent 4 Life” Targeting PCI at all who will benefit the most.
EuroInterv., 4 (2009), pp. 555-557
[9]
J. Knot, P. Widimsky, W. Wijns, et al.
How to set up an effective national primary angioplasty network: lessons learned from five European countries.
EuroInterv., 5 (2009), pp. 301-309
[10]
S. Carstensen, G.C. Nelson, P.S. Hansen, et al.
Field triage to pri-mary angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved out-come.
Eur Heart J., 28 (2007), pp. 2113-2119
[11]
P. Widimsky, T. Budesinsky, D. Vorac, et al.
Long distance transport for primary angioplasty vs. thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial: PRAGUE-2.
Eur Heart J., 24 (2003), pp. 94-104
[12]
P. Ortolani, A. Marzocchi, C. Marrozzini, et al.
Clinical impact of direct referral to primary percutaneous coronary interven-tion following pre-hospital diagnosis of ST-elevation myocardial infarction.
Eur Heart J., 27 (2006), pp. 1550-1557
[13]
F.V. Aguirre, J.J. Varghese, M.P. Kelley, et al.
Stat Heart Investigators. Rural interhospital transfer of ST-elevation myocardial infarction patients for percutaneous coronary revascularization: the Stat Heart Program.
Circulation., 117 (2008), pp. 1145-1152
[14]
R.L. McNamara, Y. Wang, J. Herrin, et al.
NRMI Investigators. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction.
J Am Coll Cardiol., 47 (2006), pp. 2180-2186
[15]
R.L. McNamara, J. Herrin, Y. Wang, et al.
Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction.
Am J Cardiol., 100 (2007), pp. 1227-1232
[16]
A. Chakrabarti, H.M. Krumholz, Y. Wang, et al.
Time-to-reperfusion in patients undergoing interhospital transfer for primary percu-taneous coronary intervention in the U.S.: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry.
J Am Coll Cardiol., 51 (2008), pp. 2442-2443
[17]
R.C. Welsh, J. Ornato, P.W. Armstrong.
Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North America.
Am Heart J., 145 (2003), pp. 1-8
[18]
J.G. Canto, N.R. Every, D.J. Magid, et al.
The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Inves-tigators.
N Engl J Med., 342 (2000), pp. 1573-1580
[19]
M. Moscucci, K.A. Fox, C.P. Cannon, et al.
for the GRACE Investiga-tors. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).
Eur Heart J., 24 (2003), pp. 1815-1823
[20]
J. Marrugat, R. Elosua, H. Martí.
Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005.
Rev Esp Cardiol., 55 (2002), pp. 337-346
[21]
R.J. Goldberg, P.G. Steg, I. Sadiq, et al.
Extent of and factors associated with delay to hospital presentation in patients with acute coronary disease (the GRACE registry).
Am J Cardiol., 89 (2002), pp. 791-796
[22]
J.G. Canto, W.J. Rogers, L.J. Bowlby, et al.
The pre-hospital electro-cardiogram in acute myocardial infarction: is its full potential being realized?.
J Am Coll Cardiol., 29 (1997), pp. 498-505
[23]
Coordenac¸ão Nacional para Doenc¸as Cardiovasculares. Alto Comissariado da Saúde. Indicadores de Actividades, Julho 2009. Available from: http://www.acs.min-saude.pt/files/2009/07/indicadores-de-actividades-2009-final.pdf.
[24]
D.P. Chew, L.J. Blows.
Randomized trials of clinical networks in the management of ST-elevation MI: can they be performed?.
Curr Opin Cardiol., 24 (2009), pp. 301-306
Copyright © 2011. Sociedade Portuguesa de Cardiologia
Baixar PDF
Idiomas
Revista Portuguesa de Cardiologia
Opções de artigo
Ferramentas
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Ao assinalar que é «Profissional de Saúde», declara conhecer e aceitar que a responsável pelo tratamento dos dados pessoais dos utilizadores da página de internet da Revista Portuguesa de Cardiologia (RPC), é esta entidade, com sede no Campo Grande, n.º 28, 13.º, 1700-093 Lisboa, com os telefones 217 970 685 e 217 817 630, fax 217 931 095 e com o endereço de correio eletrónico revista@spc.pt. Declaro para todos os fins, que assumo inteira responsabilidade pela veracidade e exatidão da afirmação aqui fornecida.